Home / Ramipril and Felodipine / Czechia
CZ ATC C09BB05 · updated 6 Nov 2026
Ramipril and Felodipine shortage in Czechia
Is there a Ramipril and Felodipine shortage in Czechia?
Yes. As of 6 Nov 2026, 1 Ramipril and Felodipine product is reported short in Czechia. The company estimate for the return is 20 Dec 2026. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | TRIASYN 2,5MG/2,5MG 2,5MG/2,5MG TBL MRL 30 anticipated | Sanofi s.r.o., Praha | 23 Nov 2026 | 20 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.